Tag: US Naval Medical Research Centre
Immuron prepares for diarrhoea-focused clinical trial as US FDA lifts clinical hold
Immuron, an Australia-based biopharmaceutical company, is slated to move forward with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) following approval from the US Food and Drug Administration (FDA).
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
